Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Marcucci

Showing results (211-220 of 536) with videos related to

Pageof 54
Sort By:
Biorxiv : the Preprint Server for Biology|June 4, 2026
Multiomic State-Transitions Reveal Post-Treatment Transcriptome Desynchronization in Acute Myeloid LeukemiaJennifer Rangel Ambriz, Ziang Chen, Yu-Hsuan Fu, et al.
Journal of Hematology & Oncology|February 7, 2025
Pharmacological activity of OST-01, a natural product from baccharis coridifolia, on breast cancer cellsHyunJun Kang, Dinh Hoa Hoang, Melissa Valerio, et al.
Plos One|March 11, 2011
The large zinc finger protein ZAS3 is a critical modulator of osteoclastogenesisShujun Liu, Francesca Madiai, Kevin V Hackshaw, et al.
Blood|May 4, 2006
Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B studyMichael D Radmacher, Guido Marcucci, Amy S Ruppert, et al.
Molecular Cancer Therapeutics|June 18, 2014
Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemiaMonica L Guzman, Neng Yang, Krishan K Sharma, et al.
Leukemia|February 2, 2024
State-transition modeling of blood transcriptome predicts disease evolution and treatment response in chronic myeloid leukemiaDavid E Frankhouser, Russell C Rockne, Lisa Uechi, et al.
Molecular Therapy. Nucleic Acids|February 4, 2022
Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkersSi-Ping Han, Lisa Scherer, Matt Gethers, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
State-transition Modeling of Blood Transcriptome Predicts Disease Evolution and Treatment Response in Chronic Myeloid LeukemiaDavid E Frankhouser, Russell C Rockne, Lisa Uechi, et al.
Blood|January 23, 2016
Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemiaQifang Zhang, Dewan Md Sakib Hossain, Priyanka Duttagupta, et al.
Cancer Research|May 3, 2008
Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemiaBjörn Hackanson, Kristi L Bennett, Romulo M Brena, et al.
Pageof 54

Showing results (211-220 of 536) with videos related to

Sort By:
Pageof 54
Biorxiv : the Preprint Server for Biology|June 4, 2026
Multiomic State-Transitions Reveal Post-Treatment Transcriptome Desynchronization in Acute Myeloid LeukemiaJennifer Rangel Ambriz, Ziang Chen, Yu-Hsuan Fu, et al.
Journal of Hematology & Oncology|February 7, 2025
Pharmacological activity of OST-01, a natural product from baccharis coridifolia, on breast cancer cellsHyunJun Kang, Dinh Hoa Hoang, Melissa Valerio, et al.
Plos One|March 11, 2011
The large zinc finger protein ZAS3 is a critical modulator of osteoclastogenesisShujun Liu, Francesca Madiai, Kevin V Hackshaw, et al.
Blood|May 4, 2006
Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B studyMichael D Radmacher, Guido Marcucci, Amy S Ruppert, et al.
Molecular Cancer Therapeutics|June 18, 2014
Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemiaMonica L Guzman, Neng Yang, Krishan K Sharma, et al.
Leukemia|February 2, 2024
State-transition modeling of blood transcriptome predicts disease evolution and treatment response in chronic myeloid leukemiaDavid E Frankhouser, Russell C Rockne, Lisa Uechi, et al.
Molecular Therapy. Nucleic Acids|February 4, 2022
Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkersSi-Ping Han, Lisa Scherer, Matt Gethers, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
State-transition Modeling of Blood Transcriptome Predicts Disease Evolution and Treatment Response in Chronic Myeloid LeukemiaDavid E Frankhouser, Russell C Rockne, Lisa Uechi, et al.
Blood|January 23, 2016
Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemiaQifang Zhang, Dewan Md Sakib Hossain, Priyanka Duttagupta, et al.
Cancer Research|May 3, 2008
Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemiaBjörn Hackanson, Kristi L Bennett, Romulo M Brena, et al.
Pageof 54